Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep486 | Diabetes (to include epidemiology, pathophysiology) | ECE2017

Insulin autoimmune syndrome: the relationship between insulin, c-peptide and glucose in active and recovering disease states

da Silva Tiago Nunes , Ferreira Ana Goncalves , Manita Isabel , Matos Ana Catarina , Carvalho Isabel , Font Paula , Prazeres Susana , Portugal Jorge

Insulin autoimmune syndrome (IAS) is a very rare cause of hypoglycaemia in western countries. One proposed mechanism is anti-insulin antibody capture of prandial insulin followed by the dissociation of insulin from anti-insulin antibody. The first objective was to study the relationship between glucose, insulin and C-peptide during a prolonged glucose load in two patients with active IAS. The second was to study the variation of these parameters between the active and the reco...

ea0010p88 | Steroids to include Cushing's | SFE2005

Non-genomic effects of the glucocorticoid receptor - the effect of glucocorticoids on activation of c-src and PKB/Akt

Kayahara M , Berry A , Ray D

Glucocorticoids (Gc) are potent anti-inflammatory agents, but their clinical use is limited by their significant side effects. The effects of glucocorticoids are mediated by the cytosolic glucocorticoid receptor (GR), which regulates transcription by transactivation or transrepression. Independent of these genomic effects of the GR are other, very rapid non-genomic effects.The glucocorticoid receptor forms a complex with hsp90, FKBP51, FKBP52 and cyp40 i...

ea0094p355 | Metabolism, Obesity and Diabetes | SFEBES2023

Long-term audit of PCSK9 inhibitor therapy: impacts on LDL-C and HbA1c in clinical practice

Farooq Qaisar , Ravat Zahra , Syed Ateeq

Background: The PCSK9 inhibitors (PCSKi), evolocumab and alirocumab, were approved by NICE in 2016, and have since proved to be efficacious in lowering LDL-C. Yet little is known about their long-term adverse effects. Genetic studies have shown patients with PCSK9 loss-of-function variants are at increased risk of T2DM. Similarly, analyses of an adverse event database found increased reports of PCSK9i-related hyperglycaemia. Meta-analyses have suggested that P...

ea0063p211 | Diabetes, Obesity and Metabolism 1 | ECE2019

Pattern of C-peptide response to oral glucose tolerance test: interest and reference values

Bonnet-Serrano Fideline , Bouzerara Amina , Abou Jaoude Mathieu , Gobeaux Camille , Mosnier-Pudar Helen , Guibourdenche Jean

Introduction: Oral glucose tolerance test (OGTT) allows classification of subjects in 3 groups, depending on glycaemia 120 minutes after 75 g glucose ingestion: normal (glycaemia < 1.4 g/L), glucose intolerant (1.4–2 g/L) and diabetic (>2 g/L). Five insulin profiles associated with different incidence rates of diabetes over 10 years of follow-up have also previously been described. Insulin measurement is very sensible to hemolysis and can advantageously be replace...

ea0029p152 | Bone &amp; Osteoporosis | ICEECE2012

Improved assessment of bone turnover by the PTH-(1–84)/ large C-PTH fragments ratio in dialysis patients

van Helden J.

Background: The ‘intact’ parathyroid hormone (PTH) assays recognizes PTH (1–84) as well as amino terminally truncated fragments (C-PTH fragments). The present study investigated whether the use of plasma PTH-(1–84)/C-PTH fragment ratio enhances the noninvasive assessment of bone metabolism in patients on dialysis.Methods: Blood samples of 45 healthy subjects with normal ‘intact’-PTH values and 135 samples of dialysis patient...

ea0073aep270 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Correlation between cystatin C and cardiovascular risk factor in patients with type 2 diabetes mellitus without kidney disease

Risovic Ivona , Vlastimir Vlatkovic2 , Pejicic Snjezana Popovic , Grbic Aleksandra , Malesevic Gabrijela

IntroductionDiabetes mellitus (DM) is considered as equivalent to cardiovascular disease (CVD), so the intensive control of all risk factors for CVD in patients with DM is recommended. Risk factors for CVD include: dyslipidemia, hypertension, smoking, family history of CVD and albuminuria. In addition to being a sensitive and reliable marker for evaluation of kidney function, research suggests that cystatin C may be a useful predictor for the detection a...

ea0081ep280 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

C-peptide response to standardized test meal in patients with newly diagnosed type 2 diabetes mellitus

Stojanovic Jelena , Andjelic Jelic Marina , Vuksanovic Miljanka , Petkovic Milica Marjanovic , Jojic Biljana , Grujanac Ana Cvetkov , Zivkovic Teodora Beljic

Background: Optimal testing of beta-cell dysfunction is still elusive. Oral based solid-food tests could superiorly approximate real-life stimulation by incorporating incretin activation. Increased body fat was recently associated with better preserved beta-cell secretory response, due to gluco-lipotoxicity induced adaptation.Objective: To assess C-peptide response to standardised test meal (STM) and its dependency on subject characteristics in newly dia...

ea0041ep859 | Pituitary - Basic | ECE2016

A C-terminal inhibitor of HSP90 decreases GH-promoter activity and growth hormone secretion in a cellular model of somatotrophinomas

Ciato Denis , Regazzo Daniela , Occhi Gianluca , Scaroni Carla , Stalla Gunter , Paez-Pereda Marcelo

Heat shock protein 90 (HSP90) plays a pivotal role in maturation and stabilization of proteins in conditions of stress. Many HSP90 client proteins are involved in oncogenic signaling and cancer progression, therefore HSP90 inhibitors have a potential as pharmaceutical agents. We reported a strong HSP90 overexpression in corticotroph adenomas and the treatment with C-terminal HSP90 inhibitors has potent anti-tumorigenic and anti-secretory effects in these tumors in vitro</e...

ea0035p702 | Male reproduction | ECE2014

Effect of 17β-estradiol on germ cell apoptosis by modulating the expression of SCF/c-kit, FasL/FasR and regucalcin

Correia Sara , Alves Mario R , Martins Ana D , Cavaco Jose E , Oliveira Pedro F , Socorro Silvia

In the last years estrogens have emerged as important regulators in male reproductive function. Spermatogenesis depends on the tight control of germ cell apoptosis and several studies indicated estrogens as playing a role in this process. The stem cell factor (SCF), a membrane-bound cytokine, and its receptor (c-kit), and the Fas ligand (FasL)/Fas receptor (FasR) system are powerful mechanisms controlling germ cell proliferation and apoptosis through the direct membrane commun...

ea0032p81 | Bone and Osteoporosis | ECE2013

Effects of the tamoxifen on calcitonin producing thyroid C cells and bone in rat model of male osteoporosis

Filipovic Branko , Pantelic Jasmina , Manojlovic-Stojanoski Milica , Trifunovic Svetlana , Nestorovic Natasa , Persinic-Popovska Florina , Jurjevic Branka sosic

Thyroid C cells produce bioregulatory peptid calcitonin (CT), which lowers plasma calcium (Ca) and acts as an inhibitor of bone resorption. In this study we investigated the effects of tamoxifen, as a selective estrogen receptor modulator on thyroid C cells and skeletal changes in middle-aged orchidectomized (Orx) rats as an animal model of male osteoporosis. Fifteen-month-old male Wistar rats were divided into Orx and a sham-operated (SO) groups. Two weeks after gonadectomy, ...